Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4501 - 4525 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
LMSL03001282
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457723 1292.949827 C71H136O17S
Gangliosides LMSP0601AJ06
  • GM3(d18:1/26:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262041 1292.869663 C67H124N2O21
LMSL05000012
  • (11S)-jalapinolic 11-O-alpha-l-rhamnopyranosyl-(1-3)-O-[4-O-n-dodecanoyl-alpha-l-rhamnopyranosyl-(1-4)]-O-[2-O-n-octanoyl]-alpha-l-rhamnopyranosyl-(114)-O-alpha-l-rhamnopyranosyl-(1-2)-O-beta-d-fucopyranoside-(1,3''-lactone)
  • Asarifolin I
166628280 1292.78566 C66H116O24
Diacylglycerophosphoinositolglycans LMGP15010101
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:2(9Z,12Z))
126457469 1292.653008 C59H105O28P
Diacylglycerophosphoinositolglycans LMGP15010122
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/14:0)
126457490 1292.653008 C59H105O28P
Gangliosides LMSP0601AJ08
  • GM3(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262043 1290.854013 C67H122N2O21
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB03
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Globoside I/Cytolipin K(d18:1/20:0)
44260174 1282.812543 C64H118N2O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AS03
  • GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260310 1282.812543 C64H118N2O23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AB03
  • Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • asialo-GM1(d18:1/20:0)
44260494 1282.812543 C64H118N2O23
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AB03
  • Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • iso-LM1(d18:1/20:0)
44260622 1282.812543 C64H118N2O23
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AA03
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • nLc4Cer(d18:1/20:0)
70699267 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AP03
  • Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261934 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT03
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261590 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF03
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261670 1282.812543 C64H118N2O23
Diacylglycerophosphoinositolglycans LMGP15010104
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/14:0)
126457472 1282.668658 C58H107O28P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA05
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261856 1281.853679 C66H123NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261624 1281.853679 C66H123NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA07
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261858 1279.838029 C66H121NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261626 1279.838029 C66H121NO22
LMSL03001281
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R-octamethyl)-17-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],16Me[R],17OH))
126457722 1278.934177 C70H134O17S
LMSL03001292
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R-octamethyl)-17-hydroxy-dotriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/32:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],16Me[R],17OH))
126457733 132145 1278.934177 C70H134O17S
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL04
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260255 1269.817294 C64H119NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO04
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260279 1269.817294 C64H119NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD04
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261655 1269.817294 C64H119NO23

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024